News AbbVie waits on data from Humira successor Ablynx's vobarilizumab seen as key should Humira sales fall.
News Imbruvica granted fourth Breakthrough status The drug is also granted Orphan Drug Designation by the FDA.
News Novartis cancer drugs among raft of NICE recommendations NICE recommends funding for lung cancer and skin cancer treatments.
News Biosimilars don't need big market share to bring savings - I... Competition can also drive down price of entire drug class.
News US regulatory advisers to review Amgen's Humira biosimilar World's biggest selling drug could face competition.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
